# E22 General Considerations for Patient Preference Studies - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/e22-general-considerations-for-patient-preference-studies/3b39fdd6-9dd0-4536-9f4d-dc3bddcc1267

> FDA guidance document: E22 General Considerations for Patient Preference Studies. Issue date: February 06, 2026. Get complete insights and analysis.

---

## Details

- Title: E22 General Considerations for Patient Preference Studies
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-02-06
- Last Changed: 2026-02-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2026-D-0207">FDA-2026-D-0207</a>

## Related Documents

- [M4Q(R2) The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality](https://www.globalkeysolutions.net/guidances/guidance-document/m4qr2-the-common-technical-document-for-the-registration-of-pharmaceuticals-for-human-use-quality/99d9c6a0-e416-4075-875d-80fbbf761ac7)
- [Q3E Guideline for Extractables and Leachables](https://www.globalkeysolutions.net/guidances/guidance-document/q3e-guideline-for-extractables-and-leachables/4b0a399e-ea86-4269-bcb2-e0cf8c88b5bd)
- [E20 Adaptive Designs for Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e20-adaptive-designs-for-clinical-trials/ea1da55a-c7ba-4a8a-bf9e-cfd6180b966c)